Navigation Links
Caliper Sciclone ALH 4000 Workstation from Caliper Life Sciences

ProductsCaliper Sciclone ALH 4000 Workstation from Caliper Life Sciences
Company Caliper Life Sciences
Item Caliper Sciclone ALH 4000 Workstation
Price 
Description The Sciclone ALH 4000 workstation is the simplest, easiest-to-use system ever for research groups seeking to introduce automated liquid handling capabilities into their labs, or groups in automated labs that need to support routine applications on a separate instrument. Plate-handling is fully automated and integrated for walk-away automation even when you have thousands of samples.

Applications:

The ALH 4000 workstation comes pre-programmed with method templates for the most popular automated liquid handling applications:

Genomics and proteomics sample prep
Hit-picking
Plate replication
Serial dilution
DNA/RNA purification
Info Caliper Life SciencesCaliper Life Sciences
Caliper Life Sciences
68 Elm St
Hopkinton, MA 01748
Customer Service: 508-435-9500
Fax Number: 508-435-3439
Web Site: http://www.caliperls.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Rapidplate from Caliper Life Sciences
2. Customized Profile from Novascreen-a Caliper Life Sciences Company
3. Neurological Profile from Novascreen-a Caliper Life Sciences Company
4. Gastrointestinal Profile from Novascreen-a Caliper Life Sciences Company
5. Cardiovascular/Renal Profile from Novascreen-a Caliper Life Sciences Company
6. General Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company
7. CNS Side Effect Profile (CNS SEP) from Novascreen-a Caliper Life Sciences Company
8. Staccato Sciclone ELISA Station from Caliper Life Sciences
9. Cell biology services from Novascreen-a Caliper Life Sciences Company
10. Hybridization Cassettes from Caliper Life Sciences
11. Staccato Custom Series from Caliper Life Sciences
... Topo I, Wild Type ... Tris-HCl, 1 mM DTT, 200 µM EDTA, 20% ... topoisomerase I (Topo I) is a monomeric protein ... gene. It catalyzes the relaxation of both positive ...
RNase-Free DNase 50 l...
Request Info...
... a DNA-dependent RNA polymerase which is stringently ... efficiently synthesizes in vitro transcripts from almost ... a T7 promoter. Transcripts can be ... vitro translation, substrates in RNA processing systems, ...
Biology Products:
(Date:6/30/2015)... , June 30, 2015 To bolster its ... provider HYPR Corp. announced today the addition of two new ... serve as board advisor and David Raviv will ... team underscore HYPR Corp.,s commitment to providing the most secure ... Dimitri Sirota co-founded Layer 7 Technologies, a provider of ...
(Date:6/25/2015)... CITY , June 25, 2015  Imagine a ... steps toward a healthier, happier life. That,s exactly what ... designed to do. The cutting-edge, portable health program provides ... real-life solutions to help improve your lifestyle and nutrition. ... awards dinner and gala Wednesday night, USANA,s THA was ...
(Date:6/24/2015)... 2015 Research and ... the "Huawei Ascend Mate 7 Fingerprint Sensor ... offering. Huawei,s technological choice for the ... than Apple,s and Samsung,s one. The Ascend Mate ... Fingerprint Cards, a main actor in capacitive sensing ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
... Yale is a founding member of the Genome-Wide RNAi ... centers formed to speed scientific and medical discoveries that ... is sponsored by Dharmacon, Inc. , manufacturer of ... of short, interfering ribonucleic acid sequences. The library is ...
... provide some of the most compelling evidence yet that ... standards--causes heart disease. Previous studies have linked air pollution ... understood how pollution damaged the body's blood vessels. , ... as polluted as the air in New York City, ...
... a swordtail fish, that is. As the size and ... preference for males with asymmetrical markings, according to a ... of biological sciences, and colleagues found that older female ... symmetrical males when offered a choice. These findings are ...
Cached Biology News:Yale participates in global human genome initiative 2Researchers show how air pollution can cause heart disease 2Researchers show how air pollution can cause heart disease 3Older female fish prefer imperfect male mates, study finds 2Older female fish prefer imperfect male mates, study finds 3
(Date:7/28/2015)... 28, 2015  Moerae Matrix Inc. announced today ... trial with MMI-0100, a first-in-class inhibitor of MAPKAP ... pulmonary disorders characterized by inflammation and fibrosis.  The ... , is a double-blind, two-way cross-over design ... and tolerability of MMI-0100 when given via inhalation ...
(Date:7/28/2015)... OF PRUSSIA, Pa. , July 28, 2015 /PRNewswire/ ... U.S. Food and Drug Administration has accepted for review ... investigational recombinant factor VIII single-chain (rVIII-SingleChain) for the treatment ... met all primary endpoints. Hemophilia ... deficient or defective factor VIII; nearly all affected patients ...
(Date:7/28/2015)... RESEARCH TRIANGLE PARK, N.C., July 28, 2015  United ... its financial results for the second quarter ended ... nearly 300% as compared to the second quarter ... said Roger Jeffs, Ph.D., United Therapeutics, President and ... was due to an increase in the number ...
(Date:7/28/2015)... 2015  Faced with increasing challenges such as ... than symptomatic, the global healthcare industry today is ... of curing or significantly changing the course of ... towards regenerative medicine as a viable alternative. ... human health with the potential to resolve unmet ...
Breaking Biology Technology:Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5